PRRT2 and glioblastoma: However, since the availability of selective inhibitors of PKC isozymes has been limited, a particular role of specific PKC isozymes in GBM progression has still remained controversial, although specific tools such as siRNA (small interfering RNA) have allowed more detailed analysis of the function of this large family [2].